ACTIONABILITY KNOWLEDGE REPOSITORY ACTIONABILITY CURATION INTERFACE
Update History
Condition: Hyperparathyroidism 2 - HPRT2
Gene/Gene Panel: CDC73
Context: Adult
Date
Status
Release
Outcomes-Interventions
Notes
2024/05/14
Released
2.0.0
A
Morbidity from CDC73-related non-parathyroid lesions (GroupB)
Evaluation and management by specialists, including imaging surveillance to guide surgery (GroupB) 6CD
Morbidity from parathyroid neoplasia (GroupA)
Evaluation and management by specialists, including biochemical and imaging surveillance to guide surgery (GroupA) 9CC
Updated report with new scoring pairs.
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
CDC73 ⇔ 0007767 HYPERPARATHYROIDISM 1; HRPT1
Moderate Actionability
Moderate Actionability
CDC73 ⇔ 0007768 HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2
Moderate Actionability
Moderate Actionability
CDC73 ⇔ 0012004 PARATHYROID CARCINOMA
Moderate Actionability
Moderate Actionability
2024/01/04
Released (Under revision)
1.2.2
A
Complications of osseous fibromas (GroupA)
Surveillance with panoramic radiograph (GroupA) 8CC
Morbidity from advanced renal lesions (GroupA)
Surveillance with renal ultrasound (GroupA) 9CC
Morbidity from primary hyperparathyroidism (GroupA)
Surveillance of parathyroid hormone and calcium (GroupA) 11CC
Internal system migration associated with MONDO name addition.
2022/02/09
Released
1.2.2
A
Complications of osseous fibromas (GroupA)
Surveillance with panoramic radiograph (GroupA) 8CC
Morbidity from advanced renal lesions (GroupA)
Surveillance with renal ultrasound (GroupA) 9CC
Morbidity from primary hyperparathyroidism (GroupA)
Surveillance of parathyroid hormone and calcium (GroupA) 11CC
Internal system migration associated with MONDO name addition.
2022/02/09
Released (Under revision)
1.2.1
A
Complications of osseous fibromas (GroupA)
Surveillance with panoramic radiograph (GroupA) 8CC
Morbidity from advanced renal lesions (GroupA)
Surveillance with renal ultrasound (GroupA) 9CC
Morbidity from primary hyperparathyroidism (GroupA)
Surveillance of parathyroid hormone and calcium (GroupA) 11CC
MONDO added
2020/08/19
Released
1.2.1
A
Complications of osseous fibromas (GroupA)
Surveillance with panoramic radiograph (GroupA) 8CC
Morbidity from advanced renal lesions (GroupA)
Surveillance with renal ultrasound (GroupA) 9CC
Morbidity from primary hyperparathyroidism (GroupA)
Surveillance of parathyroid hormone and calcium (GroupA) 11CC
MONDO added
2020/08/19
Released (Under revision)
1.2.0
A
Complications of osseous fibromas (GroupA)
Surveillance with panoramic radiograph (GroupA) 8CC
Morbidity from advanced renal lesions (GroupA)
Surveillance with renal ultrasound (GroupA) 9CC
Morbidity from primary hyperparathyroidism (GroupA)
Surveillance of parathyroid hormone and calcium (GroupA) 11CC
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/10/03
Released
1.2.0
A
Complications of osseous fibromas (GroupA)
Surveillance with panoramic radiograph (GroupA) 8CC
Morbidity from advanced renal lesions (GroupA)
Surveillance with renal ultrasound (GroupA) 9CC
Morbidity from primary hyperparathyroidism (GroupA)
Surveillance of parathyroid hormone and calcium (GroupA) 11CC
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/04/04
Released
1.1.0
A
Complications of osseous fibromas
Surveillance with panoramic radiograph 8CC
Morbidity from advanced renal lesions
Surveillance with renal ultrasound 9CC
Morbidity from primary hyperparathyroidism
Surveillance of parathyroid hormone and calcium 11CC
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.0.2
A
Complications of osseous fibromas
Surveillance with panoramic radiograph 8CC
Morbidity from advanced renal lesions
Surveillance with renal ultrasound 9CC
Morbidity from primary hyperparathyroidism
Surveillance of parathyroid hormone and calcium 11CC
Internal system migration related to score text replacement from E to N
2018/01/11
Released
1.0.1
A
Complications of osseous fibromas
Surveillance with panoramic radiograph 8CC
Morbidity from advanced renal lesions
Surveillance with renal ultrasound 9CC
Morbidity from primary hyperparathyroidism
Surveillance of parathyroid hormone and calcium 11CC
2017/09/08
Released
1.0.0
A
Complications of osseous fibromas
Surveillance with panoramic radiograph 8CC
Morbidity from advanced renal lesions
Surveillance with renal ultrasound 9CC
Morbidity from primary hyperparathyroidism
Surveillance of parathyroid hormone and calcium 11CC
¤ Powered by BCM's Genboree.